Literature DB >> 19779023

Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities.

Jordi Magrané1, Isabel Hervias, Matthew S Henning, Maria Damiano, Hibiki Kawamata, Giovanni Manfredi.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal neurological disorder characterized by motor neuron degeneration. Mutations in Cu,Zn-superoxide dismutase (SOD1) are responsible for 20% of familial ALS cases via a toxic gain of function. In mutant SOD1 transgenic mice, mitochondria of spinal motor neurons develop abnormal morphology, bioenergetic defects and degeneration, which are presumably implicated in disease pathogenesis. SOD1 is mostly a cytosolic protein, but a substantial portion is associated with organelles, including mitochondria, where it localizes predominantly in the intermembrane space (IMS). However, whether mitochondrial mutant SOD1 contributes to disease pathogenesis remains to be elucidated. We have generated NSC34 motor neuronal cell lines expressing wild-type or mutant SOD1 containing a cleavable IMS targeting signal to directly investigate the pathogenic role of mutant SOD1 in mitochondria. We show that mitochondrially-targeted SOD1 localizes to the IMS, where it is enzymatically active. We prove that mutant IMS-targeted SOD1 causes neuronal toxicity under metabolic and oxidative stress conditions. Furthermore, we demonstrate for the first time neurite mitochondrial fragmentation and impaired mitochondrial dynamics in motor neurons expressing IMS mutant SOD1. These defects are associated with impaired maintenance of neuritic processes. Our findings demonstrate that mutant SOD1 localized in the IMS is sufficient to determine mitochondrial abnormalities and neuronal toxicity, and contributes to ALS pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19779023      PMCID: PMC2773270          DOI: 10.1093/hmg/ddp421

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  46 in total

1.  Mutant Cu, Zn superoxide dismutase that causes motoneuron degeneration is present in mitochondria in the CNS.

Authors:  Cynthia M J Higgins; Cheolwha Jung; Hongliu Ding; Zuoshang Xu
Journal:  J Neurosci       Date:  2002-03-15       Impact factor: 6.167

2.  Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase.

Authors:  A G Estévez; J P Crow; J B Sampson; C Reiter; Y Zhuang; G J Richardson; M M Tarpey; L Barbeito; J S Beckman
Journal:  Science       Date:  1999-12-24       Impact factor: 47.728

3.  Development and characterisation of a glutamate-sensitive motor neurone cell line.

Authors:  C J Eggett; S Crosier; P Manning; M R Cookson; F M Menzies; C J McNeil; P J Shaw
Journal:  J Neurochem       Date:  2000-05       Impact factor: 5.372

4.  Subcellular distribution of superoxide dismutases (SOD) in rat liver: Cu,Zn-SOD in mitochondria.

Authors:  A Okado-Matsumoto; I Fridovich
Journal:  J Biol Chem       Date:  2001-08-15       Impact factor: 5.157

5.  A fraction of yeast Cu,Zn-superoxide dismutase and its metallochaperone, CCS, localize to the intermembrane space of mitochondria. A physiological role for SOD1 in guarding against mitochondrial oxidative damage.

Authors:  L A Sturtz; K Diekert; L T Jensen; R Lill; V C Culotta
Journal:  J Biol Chem       Date:  2001-08-10       Impact factor: 5.157

6.  A quantitative histochemical assay for activities of mitochondrial electron transport chain complexes in mouse spinal cord sections.

Authors:  Cheolwha Jung; Cynthia M J Higgins; Zuoshang Xu
Journal:  J Neurosci Methods       Date:  2002-03-15       Impact factor: 2.390

7.  CuZn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis-linked SOD1 mutations.

Authors:  D Jaarsma; F Rognoni; W van Duijn; H W Verspaget; E D Haasdijk; J C Holstege
Journal:  Acta Neuropathol       Date:  2001-10       Impact factor: 17.088

8.  Oligomerization of mutant SOD1 in mitochondria of motoneuronal cells drives mitochondrial damage and cell toxicity.

Authors:  Mauro Cozzolino; Maria Grazia Pesaresi; Ilaria Amori; Claudia Crosio; Alberto Ferri; Monica Nencini; Maria Teresa Carrì
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

9.  Lysyl-tRNA synthetase is a target for mutant SOD1 toxicity in mitochondria.

Authors:  Hibiki Kawamata; Jordi Magrané; Catherine Kunst; Michael P King; Giovanni Manfredi
Journal:  J Biol Chem       Date:  2008-08-20       Impact factor: 5.157

Review 10.  Recombinant aequorin and green fluorescent protein as valuable tools in the study of cell signalling.

Authors:  A Chiesa; E Rapizzi; V Tosello; P Pinton; M de Virgilio; K E Fogarty; R Rizzuto
Journal:  Biochem J       Date:  2001-04-01       Impact factor: 3.857

View more
  74 in total

1.  Increased axonal mitochondrial mobility does not slow amyotrophic lateral sclerosis (ALS)-like disease in mutant SOD1 mice.

Authors:  Yi-Bing Zhu; Zu-Hang Sheng
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

Review 2.  Import, maturation, and function of SOD1 and its copper chaperone CCS in the mitochondrial intermembrane space.

Authors:  Hibiki Kawamata; Giovanni Manfredi
Journal:  Antioxid Redox Signal       Date:  2010-11-01       Impact factor: 8.401

3.  SOD1 targeted to the mitochondrial intermembrane space prevents motor neuropathy in the Sod1 knockout mouse.

Authors:  Lindsey R Fischer; Anissa Igoudjil; Jordi Magrané; Yingjie Li; Jason M Hansen; Giovanni Manfredi; Jonathan D Glass
Journal:  Brain       Date:  2010-11-14       Impact factor: 13.501

Review 4.  Mitochondria and endoplasmic reticulum crosstalk in amyotrophic lateral sclerosis.

Authors:  Giovanni Manfredi; Hibiki Kawamata
Journal:  Neurobiol Dis       Date:  2015-08-15       Impact factor: 5.996

5.  ALS-FTLD-linked mutations of SQSTM1/p62 disrupt selective autophagy and NFE2L2/NRF2 anti-oxidative stress pathway.

Authors:  Zhiqiang Deng; Junghyun Lim; Qian Wang; Kerry Purtell; Shuai Wu; Gloria M Palomo; Haiyan Tan; Giovanni Manfredi; Yanxiang Zhao; Junmin Peng; Bo Hu; Shi Chen; Zhenyu Yue
Journal:  Autophagy       Date:  2019-07-30       Impact factor: 16.016

Review 6.  Mitochondrial metals as a potential therapeutic target in neurodegeneration.

Authors:  A Grubman; A R White; J R Liddell
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

7.  Acylation of Superoxide Dismutase 1 (SOD1) at K122 Governs SOD1-Mediated Inhibition of Mitochondrial Respiration.

Authors:  Courtney J Banks; Nathan W Rodriguez; Kyle R Gashler; Rushika R Pandya; Jeffrey B Mortenson; Matthew D Whited; Erik J Soderblom; J Will Thompson; M Arthur Moseley; Amit R Reddi; Jeffery S Tessem; Matthew P Torres; Benjamin T Bikman; Joshua L Andersen
Journal:  Mol Cell Biol       Date:  2017-09-26       Impact factor: 4.272

8.  Distinct Effects of miR-210 Reduction on Neurogenesis: Increased Neuronal Survival of Inflammation But Reduced Proliferation Associated with Mitochondrial Enhancement.

Authors:  Ludmila A Voloboueva; Xiaoyun Sun; Lijun Xu; Yi-Bing Ouyang; Rona G Giffard
Journal:  J Neurosci       Date:  2017-02-10       Impact factor: 6.167

Review 9.  The dynamics of the mitochondrial organelle as a potential therapeutic target.

Authors:  R Anne Stetler; Rehana K Leak; Yanqin Gao; Jun Chen
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-24       Impact factor: 6.200

Review 10.  Could Sirtuin Activities Modify ALS Onset and Progression?

Authors:  Bor Luen Tang
Journal:  Cell Mol Neurobiol       Date:  2016-12-10       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.